Smith & Nephew plc (LON:SN) Receives Average Rating of “Hold” from Analysts

Shares of Smith & Nephew plc (LON:SN) have been assigned a consensus recommendation of “Hold” from the nine brokerages that are covering the company, MarketBeat Ratings reports. Five investment analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is GBX 1,340.11.

A number of equities analysts recently weighed in on SN shares. Royal Bank Of Canada reissued a “sector perform” rating and issued a GBX 1,350 price target on shares of Smith & Nephew in a report on Monday, June 29th. UBS Group restated a “neutral” rating and set a GBX 1,300 price objective on shares of Smith & Nephew in a report on Tuesday, May 5th. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and issued a GBX 1,400 price objective on shares of Smith & Nephew in a research report on Thursday, June 11th. Shore Capital Group reiterated a “buy” rating and issued a GBX 1,000 target price on shares of Smith & Nephew in a research note on Tuesday, July 21st. Finally, Berenberg Bank reissued a “hold” rating and set a GBX 13 target price on shares of Smith & Nephew in a research report on Friday, May 1st.

Smith & Nephew Price Performance

Shares of LON:SN opened at GBX 1,162 on Tuesday. The company has a market cap of £12.74 billion, a P/E ratio of 41.84, a PEG ratio of 0.46 and a beta of 0.68. The company has a 50-day simple moving average of GBX 1,131.28 and a two-hundred day simple moving average of GBX 1,197.36. The company has a debt-to-equity ratio of 62.90, a current ratio of 2.57 and a quick ratio of 0.84.

About Smith & Nephew

Smith & Nephew plc, together with its subsidiaries, develops, manufactures, markets, and sells medical devices and services in the United Kingdom and internationally. It operates through three segments: Orthopaedics, Sports Medicine & ENT, and Advanced Wound Management. The company offers knee implant products for knee replacement procedures; hip implants for revision procedures; trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; and other reconstruction products.